|
HSD17B11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.37100000002977E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.80829999999866E-05 |
| Normal-vs-Stage2 |
3.55720000000392E-06 |
| Normal-vs-Stage3 |
6.563100E-04 |
| Normal-vs-Stage4 |
1.515170E-03 |
| Stage1-vs-Stage2 |
2.325600E-02 |
| Stage1-vs-Stage3 |
9.506000E-01 |
| Stage1-vs-Stage4 |
8.797600E-01 |
| Stage2-vs-Stage3 |
2.740400E-02 |
| Stage2-vs-Stage4 |
8.697700E-02 |
| Stage3-vs-Stage4 |
8.465600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54896999999821E-05 |
| Normal-vs-AfricanAmerican |
2.175600E-02 |
| Normal-vs-Asian |
7.860300E-03 |
| Caucasian-vs-AfricanAmerican |
5.393800E-01 |
| Caucasian-vs-Asian |
3.880800E-01 |
| AfricanAmerican-vs-Asian |
9.744000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.10890000000142E-05 |
| Normal-vs-Female |
1.61990999999473E-05 |
| Male-vs-Female |
8.178800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.363200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.85305000000024E-05 |
| Normal-vs-Age(61-80Yrs) |
5.77800000000073E-05 |
| Normal-vs-Age(81-100Yrs) |
3.236000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.396600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.746400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.402140E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.469200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.262310E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.191560E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.538000E-01 |
| Classical-VS-Follicular |
3.094000E-02 |
| Classical-VS-Other |
7.319200E-01 |
| Classical-VS-Normal |
2.236100E-04 |
| Tall-VS-Follicular |
1.311590E-01 |
| Tall-VS-Other |
7.413400E-01 |
| Tall-VS-Normal |
1.219760E-02 |
| Follicular-VS-Other |
5.409400E-01 |
| Follicular-VS-Normal |
3.42429999999894E-06 |
| Other-VS-Normal |
8.981400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.63520000049122E-07 |
| Normal-vs-N1 |
2.32699999999086E-05 |
| N0-vs-N1 |
9.481800E-01 |
|
|
